Arnold Tepper
Internal Medicine · Chesterfield, MONPI 1861449753
Payments from drug & device makers
Across 149 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$428
- Lilly USA, LLC$263
- Amgen$205
- Johnson & Johnson$172
- Novo Nordisk$126
- Novartis$114
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,353100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $428 |
| Lilly USA, LLC | 16 | $263 |
| Amgen | 13 | $205 |
| Johnson & Johnson | 13 | $172 |
| Novo Nordisk | 8 | $126 |
| Novartis | 7 | $114 |
| Sunovion Pharmaceuticals Inc. | 7 | $104 |
| AstraZeneca | 7 | $94 |
| Amarin Pharma, Inc. | 6 | $88 |
| Merck | 6 | $88 |
| Pfizer | 5 | $76 |
| Abbott | 5 | $76 |
| Sun Pharmaceutical Industries Inc. | 3 | $58 |
| Mylan Specialty L.p. | 4 | $57 |
| Currax Pharmaceuticals LLC | 4 | $53 |
| Eisai Inc. | 3 | $45 |
| GSK | 3 | $38 |
| Kowa Pharmaceuticals America, Inc. | 3 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Shire North American Group Inc | 1 | $23 |
| Neotract Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Nalpropion Pharmaceuticals LLC | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
How this compares
$2,353 in reported general payments places this provider in the 80th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $5,155 |
| Atorvastatin Calcium | 72 | $1,076 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $916 |
| Levothyroxine Sodium | 72 | $838 |
| Pantoprazole Sodium | 49 | $796 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 12 | $736 |
| Ranolazine ErRanolazine | 11 | $654 |
| Amlodipine Besylate | 53 | $644 |
| Tamsulosin Hcl | 33 | $554 |
| Duloxetine Hcl | 18 | $512 |
| Hydralazine Hcl | 24 | $501 |
| Olmesartan Medoxomil | 14 | $365 |
| Spironolactone | 13 | $305 |
| Enalapril Maleate | 15 | $295 |
| ClopidogrelClopidogrel Bisulfate | 14 | $292 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $76 | $5,15515 claims |
| Lilly USA, LLCOlanzapine | $263 | $11913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,097 internal medicine providers in Missouri.
Other internal medicine in Chesterfield
- Jianbo WangChesterfield$643K
- Timothy SmithSaint Peters$21.4M
- Craig DietzKansas City$4M
- Michael ReschakSaint Louis$3.1M
- Dima DandachiColumbia$1.2M
- Santosh SharmaKansas City$782K
- David PrelutskySaint Louis$575K
- Danish JabbarSaint Louis$510K
- Dubert GuerreroIndependence$369K
- Hany SalamaSaint Louis$279K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.